Bloom syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:125OMIM:210900Q82.8
Who is this for?
Show terms as
1Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Bloom syndrome (also known as Bloom-Torre-Machacek syndrome or congenital telangiectatic erythema) is a rare autosomal recessive genetic disorder caused by biallelic pathogenic variants in the BLM gene (also called RECQL3), which encodes a RecQ family DNA helicase essential for maintaining genomic stability. The hallmark of the condition is marked chromosomal instability, with greatly increased rates of sister chromatid exchanges, which underlies the dramatically elevated predisposition to a wide spectrum of cancers occurring at unusually young ages. Clinical features typically manifest in infancy and include severe pre- and postnatal growth restriction resulting in proportionate short stature, a sun-sensitive telangiectatic erythema predominantly affecting the face (especially the butterfly area of the cheeks and nose), a high-pitched voice, and a characteristic narrow, long facial appearance with a small mandible and prominent nose and ears. Affected individuals frequently experience immunodeficiency with recurrent infections, insulin resistance or diabetes mellitus, and male infertility due to absent spermatogenesis. Females may have reduced fertility but can reproduce. Mild to moderate intellectual ability is typical, though intelligence is usually normal. The most serious complication is a markedly increased risk of malignancy, including leukemias, lymphomas, and various solid tumors, often occurring in childhood or early adulthood. There is no specific curative treatment for Bloom syndrome. Management is supportive and includes strict sun protection, growth monitoring, nutritional support, surveillance for diabetes, aggressive treatment of infections, and rigorous cancer surveillance protocols. Chemotherapy and radiation doses may need to be reduced due to the underlying chromosomal fragility. The Bloom Syndrome Registry, maintained since 1960, has been instrumental in characterizing the natural history of this condition.

Also known as:

Clinical phenotype terms— hover any for plain English:

Abnormality of the immune systemHP:0002715Severe postnatal growth retardationHP:0008850Adipose tissue lossHP:0008887Cafe-au-lait spotHP:0000957
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

1 event
Jan 2026BLOOM: Pragmatic Feasibility Trial

Mayo Clinic — NA

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Bloom syndrome.

View clinical trials →

No actively recruiting trials found for Bloom syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Bloom syndrome community →

Specialists

1 foundView all specialists →
EP
Erin Barreto, PharmD, PhD
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Bloom syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Bloom syndromeForum →

No community posts yet. Be the first to share your experience with Bloom syndrome.

Start the conversation →

Latest news about Bloom syndrome

Disease timeline:

New recruiting trial: BLOOM: Pragmatic Feasibility Trial

A new clinical trial is recruiting patients for Bloom syndrome

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Bloom syndrome

What is Bloom syndrome?

Bloom syndrome (also known as Bloom-Torre-Machacek syndrome or congenital telangiectatic erythema) is a rare autosomal recessive genetic disorder caused by biallelic pathogenic variants in the BLM gene (also called RECQL3), which encodes a RecQ family DNA helicase essential for maintaining genomic stability. The hallmark of the condition is marked chromosomal instability, with greatly increased rates of sister chromatid exchanges, which underlies the dramatically elevated predisposition to a wide spectrum of cancers occurring at unusually young ages. Clinical features typically manifest in in

How is Bloom syndrome inherited?

Bloom syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Bloom syndrome typically begin?

Typical onset of Bloom syndrome is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Bloom syndrome?

1 specialists and care centers treating Bloom syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.